Pras

President Biden Selects Julie Brill as 2023 Presidential Rank Awardee

Retrieved on: 
Friday, November 3, 2023
OPM, Presidential Rank Awards, Civil Service Reform Act of 1978, Human, Federation, PRA, Senior Executive Service (United States), SL, Pras, Senior, Small business, Science, SES, Culture, SBA, Nursing, Management

WASHINGTON, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Today, Administrator Isabel Guzman , head of the U.S. Small Business Administration (SBA) and the voice for America’s 33 million small businesses in President Biden’s Cabinet is proud to recognize Julie Brill, Deputy Chief Human Capital Officer, as a recipient of the 2023 Presidential Rank Awards (PRA) chosen by President Biden.

Key Points: 
  • WASHINGTON, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Today, Administrator Isabel Guzman , head of the U.S. Small Business Administration (SBA) and the voice for America’s 33 million small businesses in President Biden’s Cabinet is proud to recognize Julie Brill, Deputy Chief Human Capital Officer, as a recipient of the 2023 Presidential Rank Awards (PRA) chosen by President Biden.
  • “Julie Brill exemplifies the best in public service.
  • This Presidential Rank Award is not only a recognition of her outstanding service but a testament to the leadership and vision she embodies.
  • The complete list of the Presidential Rank Awards can be found on OPM's website.

Fastmarkets unveils eight new Black Mass prices, reinforcing its commitment to creating transparency in Battery Raw Materials market

Retrieved on: 
Tuesday, September 19, 2023
NCM, Pras, LME, Recycling, Scrap, Collection, Nickel, LCO, Mining, PRA, Cobalt, Lithium carbonate, Conference, Lithium

This expansion cements Fastmarkets' position as a leading price reporting agency (PRA) in the battery raw materials space, offering a comprehensive suite of black mass payable indicators across Europe, Southeast Asia and South Korea.

Key Points: 
  • This expansion cements Fastmarkets' position as a leading price reporting agency (PRA) in the battery raw materials space, offering a comprehensive suite of black mass payable indicators across Europe, Southeast Asia and South Korea.
  • The new launches follow Fastmarkets' successful roll-out of payables for CIF South Korea NCM/NCA black mass in May 2023.
  • The new expansion this week means Fastmarkets increases its number of black mass payables to a total of 11 prices.
  • As mentioned in the Fastmarkets Battery Recycling and Black Mass Outlook, we expect black mass volumes to increase by around 1.7 million tonnes over the next 10 years.

Florida Cancer Specialists & Research Institute Applies For Participation in CMMI Enhancing Oncology Model

Retrieved on: 
Monday, October 31, 2022
Health, FCS, ASCO, Center, American Society of Clinical Oncology, Physician, Pras, Centers for Medicare & Medicaid Services, MD, U.S. News & World Report, Cancer, Patient, Multiple myeloma, Society, Lung, EOM, CMS, University of Florida Cancer and Genetics Research Complex, Immunotherapy, News, GLOBE, Lymphoma, Health equity, OCM, Education, LLC, Medicine, Health insurance, Medicare

Fort Myers, Fla., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute, LLC (FCS) has submitted an application to participate in Medicares Enhancing Oncology Care Model (EOM), an alternative payment model that aims to address healthcare inequities, reduce costs and improve and report outcomes for cancer patients.

Key Points: 
  • Fort Myers, Fla., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute, LLC (FCS) has submitted an application to participate in Medicares Enhancing Oncology Care Model (EOM), an alternative payment model that aims to address healthcare inequities, reduce costs and improve and report outcomes for cancer patients.
  • Michael Diaz, MD , FCS President & Managing Physician, said, We continue to scale our precision oncology capabilities that are enhancing patient experiences, advancing cancer care and improving cure rates.
  • About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
    Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida.
  • The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.

Argus completes 11th benchmark review

Retrieved on: 
Friday, October 7, 2022
Benchmark, BMR, Metal, Argus, Iosco, LPG, Argus Media, Review, Natural gas, ABA, Committee of Wise Men on the Regulation of European Securities Markets, Pras, Biofuel, Biomass, European Securities and Markets Authority, International Organization (journal), International Organization of Securities Commissions, Fertilizer, PricewaterhouseCoopers, PRA, EU, G20, Compliance, Financial Market Authority (Liechtenstein), Renewable energy, Risk management

LONDON, Oct. 7, 2022 /PRNewswire/ -- Leading global energy and commodity price reporting agency Argus has successfully completed the 11th external assurance review of its energy and commodity benchmarks and other key prices.

Key Points: 
  • LONDON, Oct. 7, 2022 /PRNewswire/ -- Leading global energy and commodity price reporting agency Argus has successfully completed the 11th external assurance review of its energy and commodity benchmarks and other key prices.
  • The prices reviewed included those published by Argus Media and those administered by Argus Benchmark Administration (ABA).
  • Argus became the first PRA to complete an independent review of oil benchmarks, in October 2013, and was the first to extend the Iosco PRA Principles to non-oil energy benchmarks, in January 2014.
  • Argus' policies and procedures, together with the full assurance review, and its price assessment methodologies are available online .

Innovative Combined Proactive Risk Assessment identifies vulnerable points in healthcare processes

Retrieved on: 
Tuesday, June 14, 2022
Editorial, RRAS, Combined, MAS, PRA, Revenue stream, Quality, Method, Database, Failure, DPT, GLOBE, Risk, RRA, VHA, PT, Patient safety, Pras, CPRA, Veterans Health Administration, Safety, Risk management, Medical device, Health care

Toward that aim, healthcare organizations continuously identify, assess and remediate sources of risk.

Key Points: 
  • Toward that aim, healthcare organizations continuously identify, assess and remediate sources of risk.
  • Reactive risk assessments (RRAs) such as incident reporting and root causes analysis and proactive risk assessments (PRAs) like failure mode and effects analysis are tools to reduce risk; however, they are generally conducted independently.
  • A new study in the June/July issue of The Joint Commission Journal on Quality and Patient Safety (JQPS), Combined Proactive Risk Assessment: An Approachable Method for Unifying Proactive and Reactive Risk Assessment Techniques in Healthcare , suggests that RRA and PRA complement one another and proposes Combined Proactive Risk Assessment (CPRA) as an innovative, approachable, scalable and generalizable technique for identifying vulnerable points in healthcare processes.
  • CPRA aligns patient safety reporting data with process steps and failure modes to assess risk.

Argus completes tenth benchmark review

Retrieved on: 
Thursday, October 7, 2021
Benchmark, Biomass, Argus Media, Biofuel, PRA, EU, G20, Natural gas, Metal, Committee of Wise Men on the Regulation of European Securities Markets, International Organization of Securities Commissions, ABA, International Organization (journal), Review, LPG, PricewaterhouseCoopers, Pras, Argus, BMR, Compliance, Iosco, European Securities and Markets Authority, Audit, Oil

LONDON, Oct. 7, 2021 /PRNewswire/ -- Leading global energy and commodity price reporting agency Argus has successfully completed the tenth external assurance review of its energy and commodity benchmarks and other key prices.

Key Points: 
  • LONDON, Oct. 7, 2021 /PRNewswire/ -- Leading global energy and commodity price reporting agency Argus has successfully completed the tenth external assurance review of its energy and commodity benchmarks and other key prices.
  • The prices reviewed included those published by Argus Media and those administered by Argus Benchmark Administration (ABA).
  • Argus became the first PRA to complete an independent review of oil benchmarks, in October 2013, and was the first to extend the Iosco PRA Principles to non-oil energy benchmarks, in January 2014.
  • Argus' description of its policies and procedures, together with the full assurance review, are publicly available , and Argus' price assessment methodologies are also online .

Fastmarkets successfully completes IOSCO assurance review of 34 metals benchmarks

Retrieved on: 
Tuesday, September 21, 2021
News, International Organization (journal), BMR, IOSCO, Compliance, Trust, Lithium, Euromoney Institutional Investor, Multimedia, European Securities and Markets Authority, Securities commission, Metal, London Stock Exchange, PRA, International Organization of Securities Commissions, LSE, Mining, Risk management, Technology, Pras, BDO, Documentation, View, Cobalt, Copper, ESMA, Euromoney, Manganese, List of parties to the Kyoto Protocol, Audit

LONDON, Sept. 21, 2021 /PRNewswire/ --Fastmarkets, the industry-leading cross-commodity price reporting agency (PRA), isdelighted to announce the successful completion of an independent assurance review of 34 key metals benchmarks.

Key Points: 
  • LONDON, Sept. 21, 2021 /PRNewswire/ --Fastmarkets, the industry-leading cross-commodity price reporting agency (PRA), isdelighted to announce the successful completion of an independent assurance review of 34 key metals benchmarks.
  • ''We remain committed to growing our list of audited prices and providing our users the highest possible level of confidence in the reliability of our benchmarks.
  • The completion of an external audit of our process demonstrates our commitment toprovide reliable, impartial, representative and transparent benchmarks,'' Fastmarkets' CEO Raju Daswani said.
  • Fastmarkets has invested significantly in resources and technology to ensure its price-assessment process aligns with IOSCO principles.

PRA’s Center for Rare Diseases Launches Toolkit to Identify and Mitigate Risks to Rare Disease Clinical Programs

Retrieved on: 
Monday, March 22, 2021
Health sciences, Clinical research, Health, Clinical trial, Design of experiments, Food and Drug Administration, Pharmaceutical industry, Pras, Rare disease, Medical research

Developed by PRAs Center for Rare Diseases in collaboration with PRAs Rare Disease Advisory Committee (RDAC) and other patient stakeholders, the toolkit includes four digital resources designed to mitigate risks that frequently occur in rare disease clinical trials.

Key Points: 
  • Developed by PRAs Center for Rare Diseases in collaboration with PRAs Rare Disease Advisory Committee (RDAC) and other patient stakeholders, the toolkit includes four digital resources designed to mitigate risks that frequently occur in rare disease clinical trials.
  • The main purpose of the toolkit is to guide sponsors in taking a more patient-centric approach in developing clinical trials, said Scott Schliebner, MPH, Senior Vice President, Center for Rare Diseases at PRA Health Sciences.
  • As an example, the toolkit includes a risk assessment tool that clinical development teams can use to identify risk to the efficiency of a clinical program.
  • PRAs rare disease experts and RDAC members recognized a gap in the availability of structured tools for operationalizing patient-centricity in rare disease clinical development.

PRA HEALTH SCIENCES ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PRAH and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, February 24, 2021
Financial economics, Corporate finance, Stock market, Finance, Equity securities, Money, Security, Common stock, Stock, Derivative, Pras

On February 24, 2021, PRA announced that it had signed an agreement to be acquired by ICON for approximately $12 billion.

Key Points: 
  • On February 24, 2021, PRA announced that it had signed an agreement to be acquired by ICON for approximately $12 billion.
  • Pursuant to the merger agreement, PRA stockholders will receive $80 in cash and 0.4125 shares of ICON common stock for each share of PRA common stock owned.
  • Bragar Eagel & Squire is concerned that PRAs board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of PRA Health Sciences, Inc. Buyout

Retrieved on: 
Wednesday, February 24, 2021
Pras, Fiduciary, PRA, ICON plc, NASDAQ, Finance, Financial markets, Companies

announces that it is investigating PRA Health Sciences, Inc. (PRA) (NASDAQ GS: PRAH ) regarding possible breaches of fiduciary duties and other violations of law related to PRAs agreement to be acquired by ICON plc (ICON) (NASDAQ GS: ICLR ).

Key Points: 
  • announces that it is investigating PRA Health Sciences, Inc. (PRA) (NASDAQ GS: PRAH ) regarding possible breaches of fiduciary duties and other violations of law related to PRAs agreement to be acquired by ICON plc (ICON) (NASDAQ GS: ICLR ).
  • Under the terms of the agreement, PRAs shareholders will receive 0.4125 shares of ICON common stock and $80.00 in cash per share.
  • To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-pra-health-sciences-inc .
  • You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected] .